AZD7648
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD7648, covering 2024-02-06 to 2024-02-06. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers. [Phase 1, Phase 2]